The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. More Details
Solid track record with mediocre balance sheet.
Share Price & News
How has Ensign Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ENSG's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: ENSG exceeded the US Healthcare industry which returned 20% over the past year.
Return vs Market: ENSG exceeded the US Market which returned 17.8% over the past year.
Price Volatility Vs. Market
How volatile is Ensign Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 days ago | Simply Wall StHere's Why I Think Ensign Group (NASDAQ:ENSG) Might Deserve Your Attention Today
2 weeks ago | Simply Wall StHow Many The Ensign Group, Inc. (NASDAQ:ENSG) Shares Did Insiders Buy, In The Last Year?
1 month ago | Simply Wall StAt US$55.61, Is It Time To Put The Ensign Group, Inc. (NASDAQ:ENSG) On Your Watch List?
Is Ensign Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ENSG ($59.49) is trading below our estimate of fair value ($217.21)
Significantly Below Fair Value: ENSG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ENSG is poor value based on its PE Ratio (24.3x) compared to the US Healthcare industry average (23.3x).
PE vs Market: ENSG is poor value based on its PE Ratio (24.3x) compared to the US market (18.9x).
Price to Earnings Growth Ratio
PEG Ratio: ENSG is poor value based on its PEG Ratio (1.6x)
Price to Book Ratio
PB vs Industry: ENSG is overvalued based on its PB Ratio (4.4x) compared to the US Healthcare industry average (3x).
How is Ensign Group forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ENSG's forecast earnings growth (14.8% per year) is above the savings rate (2.2%).
Earnings vs Market: ENSG's earnings (14.8% per year) are forecast to grow slower than the US market (22% per year).
High Growth Earnings: ENSG's earnings are forecast to grow, but not significantly.
Revenue vs Market: ENSG's revenue (8.7% per year) is forecast to grow slower than the US market (10% per year).
High Growth Revenue: ENSG's revenue (8.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ENSG's Return on Equity is forecast to be high in 3 years time
How has Ensign Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ENSG has high quality earnings.
Growing Profit Margin: ENSG's current net profit margins (5.8%) are higher than last year (3.3%).
Past Earnings Growth Analysis
Earnings Trend: ENSG's earnings have grown by 17.4% per year over the past 5 years.
Accelerating Growth: ENSG's earnings growth over the past year (130.9%) exceeds its 5-year average (17.4% per year).
Earnings vs Industry: ENSG earnings growth over the past year (130.9%) exceeded the Healthcare industry 28%.
Return on Equity
High ROE: ENSG's Return on Equity (18.4%) is considered low.
How is Ensign Group's financial position?
Financial Position Analysis
Short Term Liabilities: ENSG's short term assets ($547.3M) do not cover its short term liabilities ($581.0M).
Long Term Liabilities: ENSG's short term assets ($547.3M) do not cover its long term liabilities ($1.2B).
Debt to Equity History and Analysis
Debt Level: ENSG's debt to equity ratio (20.5%) is considered satisfactory.
Reducing Debt: ENSG's debt to equity ratio has increased from 12.6% to 20.5% over the past 5 years.
Debt Coverage: ENSG's debt is well covered by operating cash flow (203.4%).
Interest Coverage: ENSG's interest payments on its debt are well covered by EBIT (17.1x coverage).
What is Ensign Group current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ENSG's dividend (0.34%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.65%).
High Dividend: ENSG's dividend (0.34%) is low compared to the top 25% of dividend payers in the US market (4.67%).
Stability and Growth of Payments
Stable Dividend: ENSG is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: ENSG is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: ENSG is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ENSG's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Barry Port (46 yo)
Mr. Barry R. Port serves as Chief Executive Officer and Director at The Ensign Group, Inc. since May 30, 2019 and has been its President. Mr. Port has been Chief Operating Officer of Ensign Services, Inc a ...
CEO Compensation Analysis
Compensation vs Market: Barry's total compensation ($USD5.98M) is about average for companies of similar size in the US market ($USD5.63M).
Compensation vs Earnings: Barry's compensation has increased by more than 20% in the past year.
|Co-Founder & Director||1.42yrs||US$100.00k||1.76% |
|CFO & Executive VP||11.17yrs||US$5.81m||0.46% |
|Chief Investment Officer||1.42yrs||US$3.68m||0.15% |
|President & COO of Ensign Services||1.42yrs||US$2.97m||0.046% |
|VP & General Counsel||10.92yrs||US$1.65m||0.10% |
|President of Keystone Healthcare Inc||6.67yrs||no data||no data|
Experienced Management: ENSG's management team is seasoned and experienced (6.7 years average tenure).
|Co-Founder & Director||1.42yrs||US$100.00k||1.76% |
|Independent Director||6.75yrs||US$311.27k||0.052% |
|Independent Director||7.33yrs||US$311.77k||0.079% |
|Independent Director||0.75yr||no data||0.0063% |
|Independent Director||8.58yrs||US$317.77k||0.085% |
|Independent Director||1.92yrs||US$245.84k||0.016% |
|Co-Founder & Executive Chairman||1.42yrs||US$6.31m||2.68% |
Experienced Board: ENSG's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
The Ensign Group, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: The Ensign Group, Inc.
- Ticker: ENSG
- Exchange: NasdaqGS
- Founded: 1999
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: US$3.163b
- Shares outstanding: 53.17m
- Website: https://www.ensigngroup.net
Number of Employees
- The Ensign Group, Inc.
- 29222 Rancho Viejo Road
- Suite 127
- San Juan Capistrano
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ENSG||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Nov 2007|
|EGB||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Nov 2007|
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company offers transitional and skilled services, which include short and long-term ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/23 01:01|
|End of Day Share Price||2020/10/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.